Judgement of the Administrative Court of Cologne: Classification of CBD drops as medicinal products subject to authorization
Standstill in the approval process for CBD products as novel foods
What is new on preliminary injunction proceedings in pharma and biotech cases in Germany – and would it be different under the UPC?
Pharma cases: No proportionality defence without (expedited) request for compulsory license
by Verena Bertram and Dr. Nora E. Wessendorf, LL.M. (Washington)
EU Health Technology Assessment (HTA) Regulation (2021/2282) of January 11, 2022.
Background: History of the HTA Regulation
Asserting dependent claims in German patent infringement proceedings
Future gazing with Hannah Kuchler
Three hot IP issues for the pharmaceutical industry
Who's Who Legal recognises two lawyers as Global Elite Thought Leaders
by Paul Callaghan and Roland Mallinson
